What is US6596746B1, and how is it related to dasatinib?
US6596746B1 is a U.S. patent listed on Google Patents. Dasatinib (Sprycel) is a kinase inhibitor, and patents involving dasatinib are typically tied to the chemical compounds themselves, their synthesis, or their therapeutic use against cancer. To confirm whether US6596746B1 is specifically about dasatinib (as opposed to a different but related kinase inhibitor or a different compound class), you would need to open the Google Patents record and check the title, abstract, and claims for “dasatinib” or its chemical structure/name equivalents.
Because you only provided the patent number and not the patent title/abstract text, I can’t verify from the information here whether US6596746B1 is directly “the dasatinib patent” versus a neighboring patent that covers a related series of compounds or uses.
Where on Google Patents do I find the dasatinib-relevant details?
On the Google Patents page for US6596746B1, look for:
- The patent title and abstract (often mention the compound class and intended therapeutic targets).
- The “Claims” section (often includes the exact compound name, formula, or substituent definitions).
- The “Inventor” and “Assignee” fields (dasatinib-related filings are commonly associated with specific pharma assignees).
- Any “Examples” or “Preparation” sections (useful for identifying whether the chemical described matches dasatinib).
If the claims mention the exact name “dasatinib” or a synonym/chemical descriptor that matches dasatinib’s known structure, then it is directly related.
How can I check whether US6596746B1 matches the compound name “dasatinib”?
In the Google Patents page, use the browser’s find function for:
- “dasatinib”
- “Sprycel” (brand name)
- chemical synonyms if shown in the document
- key structural phrases that appear in the claims
If none of those terms appear, the patent may still be relevant to dasatinib indirectly (for example, covering a broader chemical family that includes dasatinib), but it may not be the core dasatinib-specific claim set.
Why might US6596746B1 appear in dasatinib searches even if it’s not the key dasatinib patent?
Dasatinib sits within a broader landscape of kinase-inhibitor patent literature. A patent can surface in Google Patents searches for dasatinib because of:
- Overlapping chemical classes (same general scaffold, different substitutions)
- Shared target kinases (e.g., BCR-ABL and Src-family kinases)
- Citation links (Google Patents often links related documents through forward/backward citations)
- Continuations or related priority applications in the same patent family
What do I need from you to give a precise “dasatinib” answer?
If you paste either of these from the Google Patents page for US6596746B1, I can tell you whether it’s directly about dasatinib and summarize the key claims:
- the title + abstract text, or
- the first independent claim (or the claim section that mentions the compound/formula), or
- the “Images”/“Description” portion that names the compound.
Direct Google Patents lookup
You can open the record by searching “US6596746B1” on Google Patents (or using the Google Patents URL for that number).
---
Sources
No sources were provided in your message, so I did not cite any.